234 related articles for article (PubMed ID: 16960033)
1. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
2. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
4. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
5. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
6. Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.
Riley RT; Norred WP; Wang E; Merrill AH
Nat Toxins; 1999; 7(6):407-14. PubMed ID: 11122537
[TBL] [Abstract][Full Text] [Related]
7. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
[TBL] [Abstract][Full Text] [Related]
10. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
11. [Modulation of the level of sphingomyelin cycle products and expression of the CD3 receptor in immunocompetent organs by fumonisin B1].
Martynova EA; Solov'ev AS; Khrenov AV; Zabotina TN; Alesenko AV
Biokhimiia; 1995 Apr; 60(4):618-25. PubMed ID: 7779984
[TBL] [Abstract][Full Text] [Related]
12. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B(1).
Enongene EN; Sharma RP; Bhandari N; Voss KA; Riley RT
Food Chem Toxicol; 2000 Sep; 38(9):793-9. PubMed ID: 10930700
[TBL] [Abstract][Full Text] [Related]
13. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
14. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
[TBL] [Abstract][Full Text] [Related]
15. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
18. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
[TBL] [Abstract][Full Text] [Related]
19. Instability of N-acetylated fumonisin B1 (FA1) and the impact on inhibition of ceramide synthase in rat liver slices.
Norred WP; Riley RT; Meredith FI; Poling SM; Plattner RD
Food Chem Toxicol; 2001 Nov; 39(11):1071-8. PubMed ID: 11527566
[TBL] [Abstract][Full Text] [Related]
20. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
